Curanex Pharmaceuticals Inc (CURX)
8.60
+0.41 (4.95%)
Inactive · Last trade price on Sep 12, 2025
Curanex Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
238.51M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 26.00K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCURX News
- 18 days ago - Curanex Pharmaceuticals Inc. Announces Exercise of the Over-Allotment Option by Underwriters - GlobeNewsWire
- 4 weeks ago - U.S. IPO Weekly Recap: Quiet Week As IPO Market Gears Up For A Busy Fall - Seeking Alpha
- 4 weeks ago - Curanex Pharmaceuticals Inc. Announces Closing of its Initial Public Offering - GlobeNewsWire
- 5 weeks ago - Curanex Pharmaceuticals Inc. Announces Pricing of its Initial Public Offering - GlobeNewsWire
- 1 year ago - Preclinical biopharma Curanex Pharmaceuticals files for a $10 million IPO - Renaissance Capital
- 1 year ago - Curanex Pharmaceuticals IPO Registration Document (S-1) - SEC